The authors of a paper in the Journal of Biological Chemistry (JBC) have retracted it, but don’t ask us why.
This being the JBC, the retraction notice for “Human T-cell Leukemia Virus Type I Tax Down-regulates the Expression of Phosphatidylinositol 3,4,5-Trisphosphate Inositol Phosphatases via the NF-κB Pathway” is the very definition of opaque: Continue reading Mysterious retraction in the Journal of Biological Chemistry for Takashi Tsuji’s group
The American Journal of Physiology Endocrinology and Metabolism is retracting a 2009 article by Japanese researchers who appeared to be so fond of their data they published them thrice.
The paper, “Dual suppression of adipogenesis by cigarette smoke through activation of the aryl hydrocarbon receptor and induction of endoplasmic reticulum stress,” by Masanori Kitamura and colleagues, looked at the biochemical mechanism by which cigarette smokers seem to be able to keep weight off. It has been cited eight times, according to Thomson Scientific’s Web of Knowledge.
But according to the retraction notice: Continue reading A retraction as a group’s papers on smoking and weight loss are too close for comfort
The other day we reported that Naoki Mori had lost his 23rd paper to retraction for image manipulation and duplication. Turns out we were wrong by a pretty wide margin.
The International Journal of Cancer has retracted seven more articles by the disgraced Japanese researcher, all for the same reasons:
The following article has been retracted through agreement between the first author and several coauthors, the journal Editor in-Chief, Peter Lichter, and John Wiley & Sons, Ltd. … After an investigation the retraction has been agreed due to inappropriate duplication of images and overlap with other published work.
The papers are as follows: Continue reading That’s a Mori! Seven more retractions brings latest count to 30
The retraction total for Naoki Mori continues to rise.
The October issue of Biochemical and Biophysical Research Communications has retracted a 2007 paper by Mori et al for the same issues — manipulated images — that brought down the 20-odd other papers of his since the scandal broke in late December.
Here’s the notice for the pulled paper, titled “Downregulation of citrin, a mitochondrial AGC, is associated with apoptosis of hepatocytes:” Continue reading Another retraction for Naoki Mori (make that 23?)
The Retraction Watch category for “lack of IRB approval” as a reason for retraction — a subject we covered in our most recent Lab Times column — is growing. First there were the 90-odd retractions by Joachim Boldt, then three by Australian researchers studying Aussie-rules football players. Now, we learn that the Journal of Clinical Oncology has retracted a paper over concerns that the authors failed to obtain ethical approval to conduct their study.
The 2010 publication, by researchers at Saitama Medical University in Japan, reported on an analysis of 314 lymphoma patients being treated with chemotherapy — some, and perhaps none, of whom knew they were being studied.
Here’s the notice, which appeared this month: Continue reading Lack of ethical approval leads to JCO retraction
We have an update on the case of Yoshiyuki Hattori, the Japanese endocrinologist who has had a half-dozen papers retracted because of issues involving reused data. We’ve reported on some of those retractions, and report on three new ones here.
As a trainee, Hattori spent some time in England, where he met Steven Gross, a prominent pharmacology researcher at Cornell. Gross was impressed with the young physician-scientist, and invited him back to his New York City laboratory to do a postdoc.
Gross’ name appears on one of the retracted articles, “NO suppresses while peroxynitrite sustains NF-κB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO,” which appeared in 2004 in the journal Cardiovascular Research and has been cited 42 times, according to Thomson Scientific’s Web of Knowledge.
According to the notice: Continue reading More on Hattori case from co-author: Did grudge lead to scientist’s fall?
Four neurology journals have retracted articles by a Japanese researcher who admitted to having made “mistakes” in his handling of data. Although the cases are related, the way the journals have handled the notices is startlingly different. One chose to say nothing, one chose to say little, while two went for full — or at least, approximately that — disclosure.
Guess which ones we like the most? Continue reading The ‘Goldilocks’ retraction? Revealing differences in how several neurology journals handled related problems
The authors of a 2010 Journal of Immunology paper have retracted it, saying that part of one of the figures was actually a placeholder from another experiment.
According to the retraction notice for “Stimulation of FcgRI on Primary Sensory Neurons Increases Insulin-Like Growth Factor-I Production, Thereby Reducing Reperfusion-Induced Renal Injury in Mice” by Naoaki Harada, Juan Zhao, Hiroki Kurihara, Naomi Nakagata, and Kenji Okajima: Continue reading Group under investigation retracts second paper, claims errant figure was just a placeholder
At least four retractions have appeared involving the work of a group of Japanese researchers who appear to have reused figures — and doctored them — in multiple manuscripts.
The authors, led by Yoshiyuki Hattori, of Dokkyo University School of Medicine in Mibu (whose motto, by the way, is “where character is developed through learning” a reader points out that we had the wrong Dokkyo initially), published the same figure twice, and in the same year, in the Journal of Cardiovascular Pharmacology and Biochimica et Biophysica Acta.
Here’s a retraction notice from the JCP: Continue reading New retractions of diabetes, cardiovascular papers from Japan involve repeat use of figures
Earlier this week we reported on the latest retraction of an article by Naoki Mori, number 21 in a series. We could have waited a few days and saved ourselves some trouble.
The journal Leukemia Research has retracted a 2006 paper by Mori, titled “Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.” From the notice, which is behind a paywall: Continue reading Should we change our name to Mori Watch? Yet another retraction from cancer researcher